News Image

Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17

Provided By ACCESS Newswire

Last update: May 29, 2025

STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, is rescheduling its intra-quarter webcast and investor update call to June 17, 2025, from June 3, 2025, to allow for the implementation of a reverse stock split that will become effective on June 2, 2025.

Prepared remarks by members of the Applied DNA management team will be followed by a live question-and-answer session with the Company's sell-side analysts and institutional investors.

Webcast and Conference Call Date & Time: Tuesday, June 17 @ 4:30 p.m. Eastern Time

Dial In:

A replay of the conference call will be available for 7 days following the conclusion of the call:

  • Replay for domestic callers (toll-free): 877-344-7529, replay access code 3446494

  • Replay for international callers: 412-317-0088, replay access code 3446494

  • Replay for Canadian callers (toll-free): 855-669-9658, replay access code 3446494

An accompanying slide presentation will be embedded in the webcast (live and replay) that will also be accessible as a stand-alone document via the ‘Company Presentations' page of the Applied DNA investor relations website. The webcast replay of the call will be available approximately one hour after the end of the call on the ‘Company Events' page.

About Applied DNA Sciences

Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in two business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; and (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services.

Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.

For additional information:

Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com

Web: https://investors.adnas.com/

SOURCE: Applied DNA Sciences, Inc.



View the original press release on ACCESS Newswire

APPLIED DNA SCIENCES INC

NASDAQ:APDN (5/30/2025, 8:00:00 PM)

After market: 0.3312 -0.01 (-1.9%)

0.3376

+0.01 (+3.43%)



Find more stocks in the Stock Screener

APDN Latest News and Analysis

ChartMill News Image2 days ago - ChartmillWhat's going on in today's after hours session

Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.

Mentions: AEO RRGB DGLY HBIO ...

ChartMill News Image2 days ago - ChartmillLet's take a look at the stocks that are in motion in today's session.

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Mentions: HUSA SLE RGC NAOV ...

ChartMill News Image3 days ago - ChartmillKeep an eye on the top gainers and losers in Thursday's session.

Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Mentions: SLE RGC NTLA NAOV ...

ChartMill News Image3 days ago - ChartmillThe market is filled with gapping stocks in Thursday's session.

Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Mentions: SLE AI DDC VEEV ...

Follow ChartMill for more